| pubmed-article:11762811 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11762811 | lifeskim:mentions | umls-concept:C0235782 | lld:lifeskim |
| pubmed-article:11762811 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
| pubmed-article:11762811 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:11762811 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:11762811 | pubmed:dateCreated | 2001-12-13 | lld:pubmed |
| pubmed-article:11762811 | pubmed:abstractText | Due to the high mortality rates from gallbladder carcinoma in Chile, we conducted a phase II trial to test the efficacy and safety of gemcitabine in patients with locally advanced or metastatic gallbladder carcinoma. | lld:pubmed |
| pubmed-article:11762811 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11762811 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11762811 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11762811 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11762811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11762811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11762811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11762811 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11762811 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:11762811 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:11762811 | pubmed:author | pubmed-author:RubioBB | lld:pubmed |
| pubmed-article:11762811 | pubmed:author | pubmed-author:AhumadaMM | lld:pubmed |
| pubmed-article:11762811 | pubmed:author | pubmed-author:FodorMM | lld:pubmed |
| pubmed-article:11762811 | pubmed:author | pubmed-author:YáñezMM | lld:pubmed |
| pubmed-article:11762811 | pubmed:author | pubmed-author:OrlandiLL | lld:pubmed |
| pubmed-article:11762811 | pubmed:author | pubmed-author:GamargoCC | lld:pubmed |
| pubmed-article:11762811 | pubmed:author | pubmed-author:GallardoJ OJO | lld:pubmed |
| pubmed-article:11762811 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11762811 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:11762811 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11762811 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11762811 | pubmed:pagination | 1403-6 | lld:pubmed |
| pubmed-article:11762811 | pubmed:dateRevised | 2004-12-9 | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:meshHeading | pubmed-meshheading:11762811... | lld:pubmed |
| pubmed-article:11762811 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11762811 | pubmed:articleTitle | A phase II study of gemcitabine in gallbladder carcinoma. | lld:pubmed |
| pubmed-article:11762811 | pubmed:affiliation | Sección Oncología, Hospital Clínico José Joaquín Aguirre Universidad de Chile, Santiago. jgallard@ns.hospital.uchile.cl | lld:pubmed |
| pubmed-article:11762811 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11762811 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11762811 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11762811 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11762811 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11762811 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11762811 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11762811 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11762811 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11762811 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11762811 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11762811 | lld:pubmed |
